Skip to Main Content

Paper Details

Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning.
Blood
42
2022
CD4, CD4+, CD4+ conventional T cells, CD8+, CD8+ T cells, CXCL9, Cyclophosphamide, GVHD, HLA-haploidentical (haplo), HLA-haploidentical (haplo) and HLA-matched bone, NK cell, NK cell counts, NK cells, PTCy, Patients, Tconv, Tregs, aGVHD, acute, cyclophosphamide, functional CD4+ regulatory T cells, graft-versus-host disease, immune, immune subset, inflammatory gene signatures, lymphocyte subsets, patients, recovering lymphocytes, transcriptome
Author NameAffiliation
Sophie PaczesnyIndiana University School of Medicine
Sophie PaczesnyMedical University of South Carolina
Sophie PaczesnyIndiana University School of Medicine
Sophie PaczesnyMedical University of South Carolina
Richard J JonesDepartment of Oncology and the Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine
Richard J JonesDepartment of Oncology and the Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine
  • 1 - 6

Datasets

Release 1.2